PhytoMedical in Bio-Processing Agreement With Planta Analytica

PhytoMedical Technologies, an early-stage research-based biopharmaceutical company specializing in the discovery, development and eventual commercialization of innovative plant-derived pharmaceutical and nutraceutical compounds, has announced that Connecticut-based, Planta Analytica, will undertake the extraction, fractionation and isolation of potentially active pharmacological elements in PhytoMedical's BDC-03, a plant-derived compound that has been successful in reducing body fat percentage, increasing lean muscle mass and lowering cholesterol in studies of growing animals.

Yahoo News (http://biz.yahoo.com/bw/050124/245480_1.html)